NYSE · Healthcare
PFIZER INC (PFE)
As-reported financials and recent SEC filings for PFIZER INC, latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$62.58B
Net income
$7.77B
Net margin
12.4%
Diluted EPS
$1.36
ROE
9.0%
P/E (TTM)
20.0×
Market cap
$149.38B
Debt / equity
0.7×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $62.58B | $63.63B | $59.55B | $101.17B | $81.29B |
| Gross profit | $46.51B | $45.78B | $34.60B | $66.83B | $50.47B |
| Operating income | — | — | — | — | — |
| Net income | $7.77B | $8.03B | $2.12B | $31.37B | $21.98B |
| Diluted EPS | $1.36 | $1.41 | $0.37 | $5.47 | $3.85 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-06-01
View on EDGAR →42026-05-18
View on EDGAR →SCHEDULE 13G/A2026-05-12
View on EDGAR →13F-HR2026-05-12
View on EDGAR →S-82026-05-05
View on EDGAR →10-Q2026-05-05
View on EDGAR →8-K2026-05-05
View on EDGAR →42026-05-04
View on EDGAR →Go deeper on PFE
Search PFIZER INC’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.